logo
welcome
Reuters

Reuters

US FDA approves Eli Lilly's drug for eczema

Reuters
Summary
Nutrition label

81% Informative

Ebglyss is a monoclonal antibody that selectively targets and neutralizes the IL-13 protein that causes progression of eczema.

The FDA 's approval was based on three studies involving over 1,000 patients.

Nearly 16.5 million adults in the U.S. have Eczema , also known as atopic dermatitis, which can cause itching, rashes and dry patches.

VR Score

91

Informative language

97

Neutral language

78

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links